MENU
ENSC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ensysce Biosciences (ENSC) Ownership - Who owns Ensysce Biosciences?
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs... Show more
Profile
Industry
N/A
Address
7946 Ivanhoe Avenue
Phone
+1 858 263-4196
Employees
9
Web
https://www.ensysce.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.41M
P/E Ratio
N/A
Total Cash
3.5M
Projected Growth
N/A
Total Debt
301.66K
Revenue
N/A
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash/Share
2.13
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ENSC
Capitalization
5.41M
P/E Ratio
N/A
Risk (Beta)
0.30
Dividend Yield
N/A
Total Cash
3.5M
Total Cash/Share
2.13
Total Debt
302K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
3.71M
P/B Ratio
1.46
Cash Flow
N/A
Earnings
-11.45
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
136
Current Ratio
2.42
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-6.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-192.34
Shares Held By Institutions
1.19M
Shares Outstanding - Current
1.65M
Total Liabilities
2.22M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-59.582
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
7946 Ivanhoe Avenue
Phone
+1 858 263-4196
Employees
9
Web
https://www.ensysce.com